top of page
The Professional Network for Healthcare Experts
Merck KGaA agrees $1.3 billion acquisition of Silence Therapeutics to expand rare disease siRNA pipeline
Merck KGaA has agreed to acquire Silence Therapeutics in an all-cash transaction valued at approximately $1.3 billion in equity, expanding its RNA interference pipeline.
nuaxia
4 days ago2 min read
US Hematologist Compensation Reaches $446,700 in Doximity’s 2026 Report
Average annual compensation for US hematologists reached $446,700 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in hematology.
nuaxia
Sep 43 min read
FDA approves Besremi for adults with essential thrombocythemia
The FDA has approved Besremi for adults with essential thrombocythemia, extending ropeginterferon alfa-2b-njft into a second myeloproliferative neoplasm indication in the United States.
nuaxia
Sep 12 min read
FDA approves Mimrylo for adults with polycythemia vera
Mimrylo is the first FDA-approved polycythemia vera treatment designed to mimic hepcidin, targeting the iron availability that drives excessive red blood cell production.
nuaxia
Sep 12 min read
bottom of page